Fundraising FoxMoat Biotechnology
Oklahoma City, US · Founded 2022 · Delaware LLC · 2 known investors
Find your way into Moat Biotechnology
Sign up to see every warm intro you have to Moat Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Moat Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RP
Russell P. RotherNamed on SEC filing
SA
Scott A. RollinsNamed on SEC filing
PJ
Philip JonesNamed on SEC filing
RA
Richard AlvarezNamed on SEC filing
Board
TF
MM
PJ
Phillip JonesBoard director
Investors · 2
Cortado VenturesreportedOklahoma City
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 3 rounds · 2022–2025
▶$26.4KraisedOct 2025 · 1 investors · BiotechnologyRule 506(b)
▶$26.4KraisedOct 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Russell P. RotherExecutive Officer, Director, Promoter
- Tetherex Pharmaceuticals CorporationPromoter
- Michael Moradi-AraghiDirector
- Scott A. RollinsExecutive Officer, Director, Promoter
- Todd FoleyDirector
- Phillip JonesDirector
- Offering amount
- $15.6M
- Amount sold
- $26.4K
- Minimum investment
- $26.4K
- Finders' fees
- $800K
- Proceeds to insiders
- $4.5M
- First sale
- Oct 2025
- Incorporated
- Limited Liability Company, Delaware, 2022
- Federal exemptions
- 06b
▶$101.6KraisedFeb 2023 · 2 investors · BiotechnologyRule 506(b)
▶$101.6KraisedFeb 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip JonesDirector
- Richard AlvarezExecutive Officer
- Tetherex Pharmaceuticals CorporationPromoter
- Russell RotherExecutive Officer, Director, Promoter
- Scott A. RollinsExecutive Officer, Director, Promoter
- Todd FoleyDirector
- Offering amount
- $20M
- Amount sold
- $101.6K
- Minimum investment
- $50.8K
- Proceeds to insiders
- $3.1M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.5MraisedOct 2022 · 2 investors · BiotechnologyRule 506(b)
▶$1.5MraisedOct 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip JonesDirector
- Tetherex Pharmaceuticals CorporationPromoter
- Todd FoleyDirector
- Richard AlvarezExecutive Officer
- Scott RollinsExecutive Officer, Director, Promoter
- Russell RotherExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $250K
- Proceeds to insiders
- $1.5M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Moat Biotechnology's investors?
- Moat Biotechnology's investors include Cortado Ventures, MPM BioImpact.
- How much funding has Moat Biotechnology raised?
- Moat Biotechnology has disclosed $1.6M raised across 3 rounds.
- Where is Moat Biotechnology headquartered?
- Moat Biotechnology is headquartered in Oklahoma City, US.